Continuous monitoring of biomarkers is essential for early disease detection, treatment evaluation, and personalized health management, yet most clinical tests rely on invasive, single-point blood ...
(a, b) Design of anticoagulant fibers carrying NU172 and RA-36 aptamers with three possible aptamer locations within the fibers being indicated. (c) Binding of anticoagulant fibers to thrombin, ...